PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 8, 2000, Pages 2096-2102

  Stroop, William G ^a,b   Chen, Tsuey Ming ^b   Chodosh, James ^c,d   Kienzle, Thomas E ^a,b   Stroop, Janice L ^a   Ling, Jeng Yang ^a,b   Miles, Dorothy A ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; ROSE BENGAL; SINGLET OXYGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNE DEFICIENCY; NONHUMAN; PHOTOREACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; VIRUS CULTURE; VIRUS INFECTIVITY;

ANIMALS; ANTIVIRAL AGENTS; CORNEA; DNA, VIRAL; FLUORESCENT DYES; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; LISSAMINE GREEN DYES; POLYMERASE CHAIN REACTION; RABBITS; ROSE BENGAL; TIME FACTORS; VIRUS CULTIVATION;

EID: 0033937810     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Vision Research, a National Plan: 1994-1998. A Report of the National Advisory Eye Council: National Institutes of Health, National Eye Institute. Bethesda, MD: NIH Publication No. 93-186:138.
2. Norn MS. Desiccation of the precorneal tear film, I: corneal wetting time. Acta Ophthalmol. 1969;47:865-880.
3. Mishima S, Gasset Am Klyke SD, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol. 1966;5:264-276.
4. Wilson FM. Rose bengal staining of epibulbar squamous neoplasms. Ophthalmic Surg. 1976;7:21-23.
5. Chodosh J, Banks MC, Stroop WG. Rose bengal inhibits herpes simplex virus replication in VERO and human corneal epithelial cells in vitro. Invest Ophthalmol Vis Sci. 1992;33:2520-2527.
6. Chodosh J, Dix RD, Howell RC, Stroop WG, Tseng SCG. Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B. Invest Ophthalmol Vis Sci. 1994;35:1046-1058.
7. Roat MI, Romanowski E, Araulio-Cruz T, Gordon J. The antiviral effects of rose bengal and fluorescein. Arch Ophthalmol. 1987; 105:1415-1417.
8. McGeoch DJ, Dalrymple MA, Davison AJ, et al. The complete sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 1988;69:1531-1574.
9. Neufeld MV, Steinemann TL, Merin LM, Stroop WG, Brown MF. Identification of a herpes simplex virus-induced dendrite in an eye-bank donor cornea. Cornea. 1999;18:489-492.
10. Stroop WG, Schaefer DC. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. Invest Ophthalmol Vis Sci. 1987;28:229-237.
11. Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex viras. J Infect Dis. 1986;153:721-731.